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Abstract Leptin is involved in the lung epithelial
homeostasis. Its role in the nasal tract is largely unknown.
Allergic rhinitis (AR) is induced by the allergen exposure
leading to consequential structural abnormalities in the
nasal epithelium. Topical corticosteroids are recommended
as first-line therapy in AR. Parietaria pollen is one of the
most important allergenic sources in the southern Europe.
In vitro, in human nasal epithelial cell line RPMI 2650, we
aimed to determine whether allergen stimulation acts on
leptin/leptin receptor pathway and how fluticasone furoate
(FF) influences this pathway. The effects of the major
allergen recombinant Par j 1 (rPar j 1), of FF, of leptin, and
of TGF-b1 on cell proliferation, on leptin/leptin receptor
expression and modulation (by clonogenic test, by RT-q-
RT-PCR, by immunocytochemistry and by flow-cytome-
try), and on STAT-3 activation (assessing nuclear
translocation by western blot analysis) were assessed. We
found that rPar j 1 and TGF-b1 significantly decreased cell
proliferation and down-regulated the leptin/leptin receptor
pathway, whereas FF and leptin reverted them, both alone
and in combination. Furthermore, rPar j 1 reduced, while
leptin and FF increased STAT-3 activation. In conclusion,
FF and leptin itself are able to preserve nasal epithelial
homeostasis restoring the leptin/leptin receptor pathway
altered by rPar j 1 exposure.
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Introduction
Leptin adipokine bridges the nutritional status and the
immune system, as it has been recognized to be a pleio-
tropic molecule involved in a variety of physiological
functions in both the central nervous system and the
periphery [1, 2]. Leptin exerts its roles through several
forms of its receptor, expressed in numerous cytotypes
including neurons, epithelial cells, and immune cells. Upon
leptin binding to the extracellular binding domain of its
receptor long form, ObRb, JAK2 becomes activated and
phosphorylates three tyrosine residues on ObRb (Tyr 985,
1077, and 1138) that are in turn recognized by STAT3.
Following phosphorylation of STAT3, there is initiation of
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multiple downstream signaling events mediates by leptin
[3]. Long-term leptin replacement therapy restores CD4
numbers, IFN-c expression, and T-cell function while
decreases TGF-b to normal levels [3]. In the lung, recent
observations suggest a modulatory role for leptin in pul-
monary development and identify the leptin receptor as a
physiological marker of fetal lung maturity [2] and of
epithelial cell proliferation [4]. In the respiratory tract,
leptin has a role in the regulation of immune cells [2, 5] as
well as in maintaining epithelial homeostasis [6]. The
positive regulation of cell proliferation is an event crucially
involved in the repair processes also in nasal epithelium. In
the nasal tract, upon injury, undifferentiated basal cells
migrate from adjacent epithelium, spread over the denuded
basement membrane, and proliferate in injured regions [7].
Despite leptin playing different roles in the olfactory
mucosa cells [8], in the human nasal epithelium, its role is
still largely unexplored.
Allergic rhinitis (AR) affects 400 million people
worldwide [9]. It is a chronic inflammatory disorder med-
iated by response to natural allergen exposure and repre-
sents an important health problem due its prevalence and
its impact on patients’ social life, school-performance, and
work productivity [10]. Often AR is part of a systemic
inflammatory process associated with other inflammatory
disorders including asthma. A previous our in vitro and
ex vivo study aimed to assess the role of leptin/leptin
receptor on asthma remodeling concludes that this pathway
is involved in lung epithelial homeostasis in asthma, and its
expression is inversely correlated with airway remodeling,
including reticular basement membrane and TGF-b1
expression [6].
The RPMI 2650 nasal epithelial cell line represents a
valid in vitro model to evaluate the regulation of TGF-b
biology [11] and for rhinoshinutis [12]. The uses of intra-
nasal corticosteroids, patients’ education, and prevention of
allergen contact are all important tools for optimal symp-
tom control in AR patients [9]. Particularly, the treatment
with intranasal fluticasone propionate for 1 year increases
the thickness of the nasal epithelium, and this phenomenon
could be associated to repair events in response to injury
due to chronic inflammation [13]. Parietaria judaica
belongs to the genus of dicotyledonous weeds of the Ur-
ticaceae family, and its pollen grain is one of the major
sources of allergens in the Mediterranean area. Its major
allergens (Par j 1 and Par j 2) have been sequenced and
characterized [14, 15]; particularly, recombinant Par j 1
(rPar j 1) is a small protein of 14.400 Da, belonging to
‘‘Plant non-specific lipid transfer proteins’’ (nsLTP), small
cysteine-rich lipid-binding proteins involved in plant
resistance to biotic and abiotic stresses, widely distributed
in the plant kingdom. Based on all these evidences, the
present study was performed to investigate, in vitro in
RPMI cells, the role of leptin/leptin receptor pathway on
epithelial homeostasis in the presence or absence of fluti-
casone furoate (FF), of rPar j 1, of leptin itself, and of TGF-
b1.
Materials and methods
Reagents
rPar j 1, fully named Par j 1.0201 (EMBL accession
number X85012), was generated as previously described
[14]. This recombinant protein was tested for the endo-
toxin content using the multi-test limulus amebocyte
lysate (LAL) pyrogen plus test (Bio-Whittaker, USA)
(endogenous endotoxin content B0.003 ng LPS/lg of
recombinant protein). FF was provided by Glaxo-
SmithKline, and it was solved in N,N-dimethylacetamide
(D5511) was purchased from Sigma Aldrich. Recombi-
nant human leptin and recombinant human TGF-b1 were
purchased from R&D Systems. The polyclonal anti-leptin
(Ob A-20: sc 842), anti-leptin receptors (Ob-R M-18: sc-
1834), the monoclonal anti-STAT-3 (STAT-3 F-2: sc-
8019) antibodies, and the fat dry milk were from Santa
Cruz Biotechnology. Pharmacological JAK2 inhibitor AG
490 (cat# 658401) was from Calbiochem. TRIzol
Reagent and oligo(dT)12-18 primer were from Invitro-
gen, FAM-labeled probe, and primers from Applied
Biosystems.
RPMI 2650 cultures and treatments
RPMI 2650 cell lines (ATCC-CCL-30) were purchased
from American Type Culture Collection (ATCC; Rock-
ville, MD, USA). Cells were cultured in complete culture
medium (MEM minimum essential media containing
10 % FCS, L-glutamin 2 mM, gentamicin 50 mg/ml,
MEM NEAA 0.5 %, sodium pyruvate 1 nM, HEPES
1 %) in the presence or absence of rPar j 1 (1 lg/ml), FF
(10-8 M), recombinant human leptin (0.5 lM) [6], and
recombinant human TGF-b1 (2 ng/ml) [6], alone or
together combined, for 24 h. Preliminary experiments for
leptin receptor expression were performed to establish the
best drug concentration (Fig. S1) and the best time point
(Fig. S2).
Stainings for leptin and leptin receptors
Cytospins were prepared from RPMI 2650 cultured without
any stimulations, and cells were fixed and permeabilized as
previously described [6]. After washing in PBS, slides were
incubated with the primary antibodies anti-leptin (1:40, 1 h
RT) and anti-leptin receptor against the common part of the
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short and long isoform (1:50, overnight 4 C). BSA 0.5 %
in TBS was used as blocking agent.
The reaction was revealed by universal LSAB KIT
phosphatase method (DAKO Glostrup, Denmark) includ-
ing a mixture of secondary antibodies at fixed concentra-
tion. Non-immune IgG at the same titer as the primary
antibodies was used as a negative controls. Cytospins were
examined under light microscopy with a final magnifica-
tion of 1,0009. Moreover, to better gain inside to the
mechanism of allergen exposure, immunohistochemistry
stainings were also performed as previously described [6]
on 5-lm-thick paraformaldehyde-fixed paraffin-embedded
tissue sections from inferior turbinate of nasal biopsies
from three healthy not allergic control subjects and from
three allergic patients. The study protocol was approved by
the Policlinico Ethic Committee (13/2013) and informed
written consent was obtained from each patient. Immuno-
stainings were performed at RT, 1 h using rabbit poly-
clonal anti-leptin (1:40) and at 4 C overnight using goat
polyclonal anti-leptin receptor (1:50). Control Abs were
used as negative controls. Slides were analyzed by Leica
light microscope (1,0009) by using Quantimet 500 MC
software (Leica) for image analysis.
Flow-cytometry for leptin and leptin receptor proteins
RPMI 2650 cell line was analyzed for leptin/leptin receptor
expression by FACScalibur (Becton–Dickinson, Mountain
View, CA, USA) flow cytometer in the presence of the
described stimuli. FF diluent (N,N-dimethylacetamide
D5511), at the same concentration used to dilute FF, was
also tested. Detection of intracellular leptin and of leptin
receptors was performed as previously described [4] by
using the specific polyclonal antibodies for leptin and for
leptin receptors. To evaluate the expression of intracellular
leptin, cells were treated overnight with GolgiStop (2 lM
final concentration) (BD PharMingen) and fixed with PBS
containing 4 % paraformaldehyde for 20 min at room
temperature. Fixed cells were washed twice in permeabi-
lization buffer (PBS containing 1 % FBS, 0.3 % saponin,
and 0.1 % Na azide) for 5 min at 4 C and then incubated
with rabbit polyclonal antibody anti-leptin (1:25; for 1 h).
For assessing leptin receptors, unpermeabilized cells were
incubated with goat polyclonal anti-leptin receptor anti-
body (1:25; for 1 h). Polyclonal Swine Anti-Rabbit
Immunoglobulins/FITC (Dako; Code Nr. F 0054) (1:25; for
1 h) for leptin and polyclonal Rabbit Anti-Goat Immuno-
globulins/FITC (Dako; Code Nr. F 0250) (1:25; for 1 h) for
leptin receptor were used as secondary antibodies. Per-
centages of positive cells for leptin receptors and mean of
positive cells for leptin were determined from forward (FS)
and sideways (SS) scatter patterns, after gating on the cells,
excluding debris. Non-specific binding and background
fluorescence were quantified by analyzing negative
controls.
Clonogenic assay
The colony growth of RPMI 2650 cells exposed to the
previously described stimuli was assessed. In addition, the
condition with pharmacological JAK2 inhibitor AG 490,
alone or in combination with FF, with leptin, and with r
PRJ1 was performed. Using 35-mm Petri dishes (Falcon,
Becton–Dickinson, Franklin Lakes, NJ, USA), a lower
layer was prepared using complete MEM medium in 0.5 %
agarose. The cells were harvested and seeded (5 9 104) on
the upper layer with 0.3 % agarose prepared with the same
medium as the lower layer and finally incubated for
21 days at 37 C in an atmosphere containing 5 % CO2. At
the end of incubation, colonies were counted under an
inverted phase-contrast microscope (Leitz, Wetzlar, Ger-
many). The experiments were conducted in triplicate.
Colonies were defined as cell aggregates with at least 40
cells. The true number of colonies was calculated as the
number of aggregates on the positive control subtracted
from the number of colonies on the experimental plates.
Results are expressed as percentages of the control value.
Quantitative real-time reverse transcription-polymerase
chain reaction (RT-PCR) of leptin receptors
Total RNA was extracted from RPMI 2650 cells and cultured
with TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) in the
presence of the previously described stimuli, following the
manufacturer’s instructions. 4lg of total extracted cellular
RNA was reverse-transcribed, using M-MLV-RT and oli-
go(dT)12-18 primer (Invitrogen), into cDNA in a 20 ll vol-
ume reaction mixture. Furthermore, 10 % cDNA aliquots
(2 ll) from reverse reaction were used as templates for real-
time PCR amplification (approximately 20 ng of cDNA).
Quantitative real-time PCR of leptin and of the common part
of the short and long form of human leptin receptor transcripts
was carried out on Step One Plus Real-time PCR System
(Applied Biosystems, Foster City, CA, USA) using specific
FAM-labeled probe and primers (prevalidated TaqMan Gene
expression assay for leptin, Hs00174877m1, and for leptin
receptor, Hs00174492m1; Assays on Demand, Applied Bio-
systems). Leptin and leptin receptor gene expression was
normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) endogenous control gene. Relative quantization of
gene expression was calculated with the comparative CT
method (2DDCT ) [15] and was plotted as fold-change com-
pared to untreated cells, chosen as the reference sample.
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Western blot analysis for STAT-3
Western blot analysis for Signal transducer and activator of
transcription (STAT)-3 was performed as previously
described [16] with some modifications. To study STAT-3
nuclear translocation, the protein extracts were treated to
separate the cytoplasmic and nuclear protein fractions by
using a commercial kit ‘‘NE-PER Nuclear and Cytoplasmic
Extraction Reagents’’ following the manufacturer’s direc-
tions (Thermo Scientific; Waltham, MA, USA). An amount
of 40 lg of total proteins was subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
on 10 % gels and blotted onto nitrocellulose membranes.
These were blocked with PBS containing 5 % no fat dry
milk (for 1 h; room temperature), 0.1 % Tween 20, and
then probed with the antibody anti-Stat3 (1:100; overnight)
and a goat anti-mouse antibody (1:1,000; 1 h) (Amersham
Biosciences, Piscataway, NJ, USA). Revelation was per-
formed with an enhanced chemioluminescence system (GE
Healthcare, Chalfont St. Giles, UK) followed by autoradi-
ography. The expression of beta-actin (Sigma) and lamin
B1 as housekeeping proteins for cytoplasmic and nuclear
extracts, respectively, was assessed by using goat poly-
clonal anti-b-actin and rabbit polyclonal anti-lamin B1
(Cell Signaling, Danvers, MA, USA).
Statistical analysis
Results are expressed as mean ± SD. Paired t test was
performed. Kolmorogov–Smirnov Normality test was ini-
tially performed to assess whether parametric analyses of
data could have been performed. A P value of less than
0.05 was considered as statistically significant.
Results
RPMI 2650 cells express leptin and its receptors
In our in vitro model, we first assessed, by immunocyto-
chemistry analysis and by flow cytometry, whether RPMI
2650 cells constitutively expressed leptin and its receptor
proteins. These cells expressed both proteins in the absence
of any stimuli (Fig. 1a, b). Ex vivo approaches confirmed
that nasal epithelial cells expressed leptin and its receptors
(as demonstrated by a red ring staining) and showed a trend
of reduction for leptin and leptin receptor expressions in
allergic patients in comparison to control subjects (Fig. 2a,
b). Negative control Abs demonstrated no significant im-
munostainings (data not shown).
Effect of rPar j 1, FF, and cytokines on RPMI 2650 cell
proliferation
Since leptin/leptin receptor pathway exerts a proliferative
role in various cell lines [17] including some bronchial
epithelial cell lines [4, 6], we investigated whether this
pathway was involved in the proliferative events (assessed
by colony numbers) of nasal epithelial cells and whether
rPar j 1, leptin, and TGF-b1, in the absence and in the
presence of FF. Interestingly, significantly higher colony
numbers were observed in RPMI 2650 cells cultured with
Fig. 1 RPMI 2650 cells
express leptin and leptin
receptors.
a Immunocytochemistry was
performed for assessing leptin
and leptin receptor in RPMI
2650 cells. Right corners
negative controls. Magnification
at 91,000. b Flow-cytometry
analysis was performed for
assessing leptin and leptin
receptor in RPMI 2650 cells.
Overlay of fluorescence
intensity (FL1) related to
expression of leptin and leptin
receptors versus events
histogram of cells cultured in
medium. Left gray peaks
negative controls
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FF and with leptin alone (p \ 0.03 and p \ 0.0002,
respectively), in comparison to medium alone (Fig. 3). On
the other hand, significantly lower colony numbers were
found in RPMI 2650 cells cultured with rPar j 1
(p \ 0.002) and with TGF-b1 (p \ 0.03) alone in com-
parison to medium alone. The incubation with FF and rPar
j 1 and with FF and TGF-b1 in combination was able to
restore the cell proliferation and to significantly increase
the colony numbers in comparison to rPar j 1 (p \ 0.0002)
or to TGF-b1 (p \ 0.008) alone (Fig. 3). Leptin in com-
bination with rPar j 1 had no effect on cell proliferation.
Finally, the use of the pharmacological JAK2 inhibitor AG
490 was able to completely abolish the activity of leptin on
cell proliferation (p \ 0.0005), whereas it was able to
counteract the proliferative effect of FF only when FF was
present in combination with rPar j 1 (p \ 0.02) suggesting
that FF restores cell proliferation, reduced by rParj 1
exposure, by activating JAK2, a signal crucially involved
in leptin/leptin receptor pathway (Fig. 3).
Effect of rPar j 1, FF, and cytokines on leptin and leptin
receptor mRNA
To gain insight the mechanisms related to allergen expo-
sure and corticosteroid treatment, we tested the effects of
rPar j 1, of FF, of leptin, and of TGF-b1, alone and dif-
ferently combined, on leptin and leptin receptor mRNA
modulation. FF alone and in combination with leptin sig-
nificantly increased the constitutive leptin receptor mRNA
(p \ 0.001 and p \ 0.005, respectively) (Fig. 4a). Fur-
thermore, leptin, alone and in combination with rPar j 1,
significantly increased the constitutive leptin receptor
mRNA (p \ 0.03 and p \ 0.001, respectively). rPar j 1,
TGF-b1, and the association of FF and rPar j 1 had no
effect on the modulation of the leptin receptor mRNA
(Fig. 4a). All the tested stimuli were not able to modulate
the leptin mRNA (Fig. 4b).
Effect of rPar J 1, FF, and cytokines on leptin/leptin
receptor proteins
We next evaluated the ability of rPar j 1, FF, recombinant
human leptin and, TGF-b1, alone or in combination, to
modulate the expression of leptin and leptin receptor pro-
teins in RPMI 2650 cells. rPar j 1 and TGF-b1 significantly
decreased the leptin receptors expression in comparison to
control (p \ 0.02 and p [ 0.04, respectively). On the other
hand, FF significantly increased constitutive leptin receptor
expression (p \ 0.02) and, when added to the cultures in
combination to rPar j 1, was able to counteract its
Fig. 2 Expression of leptin and leptin receptor in nasal biopsies.
Inferior turbinate of nasal biopsies was collected from healthy not
allergic control subjects (n = 3) and from allergic patients (n = 3).
Leptin and leptin receptor were assessed by immunohistochemistry.
Representative immunostaining in a healthy subject (a) and in a
patient with allergic chronic rhinitis (b). The bars represent 10 lm,
and the arrows indicates the epithelial cells. 9400 magnification
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downregulatory effect (p \ 0.03) (Fig. 5a, b). With regard
to leptin protein expression, rPar j 1 significantly decreased
(p \ 0.003), whereas leptin and FF significantly increased
(p \ 0.05 and p \ 0.03, respectively) the expression of this
protein in RPMI 2650 cells. When FF was added to the
cultures in combination to rPar j 1, it was able to counteract
Fig. 4 rPar j 1, FF, and
cytokines affect mRNA for
leptin receptors. a This panel
shows data for leptin receptors
mRNA expression by real-time
reverse transcription-PCR
assays. GAPDH gene is used for
normalization. Data are
expressed as fold induction over
baseline condition. Data
(mean ± SD) from three
independent experiments.
Significant difference * versus
medium. p \ 0.05, paired t test.
b This panel shows data for
leptin mRNA expression by
real-time reverse transcription-
PCR assays. GAPDH gene is
used for normalization. Data are
expressed as fold induction over
baseline condition.
Representative data from two
independent experiments
Fig. 3 rPar j 1, FF, and cytokines affect RPMI 2650 cell prolifer-
ation. This panel shows data (mean ± SD) from five independent
experiments. Gray histograms are with inhibitor AG 490. Significant
difference * versus medium; ** versus rPar j 1; # versus TGFb1; §
versus medium ? AG 490; §§ versus leptin. p \ 0.05, paired t test
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the rPar j 1 downregulatory effect (p \ 0.007) (Fig. 6). No
effect on leptin protein expression was exerted by TGF-b1
and leptin in combination with rPar j 1 (data not shown).
The diluent of FF had no effect on both leptin and leptin
receptors protein expression (data not shown).
Effect of rPar j 1, FF, and leptin on STAT-3 nuclear
translocation
Since the activation of leptin/leptin receptor pathway leads
to JAK2 activation and in turn to STAT-3 activation (3),
the effects of rPar j 1, of FF, and of recombinant human
leptin on STAT-3 nuclear translocation were evaluated.
After 24 h of incubation, rPar j 1 significantly decreased
the STAT-3 activation (p \ 0.04). FF significantly
increased the activation of STAT-3 (p \ 0.02) and signif-
icantly counteracted rPar j 1 downregulatory effects
(p \ 0.004) (Fig. 7a). Leptin, at both 4 and 24 h of incu-
bation, was not able to significantly counteract rPar j 1
effects (Fig. 7a). Leptin increased STAT-3 activation in a
time-dependent manner reaching the maximum after 4 h of
incubation (p \ 0.02) and starting to decrease at 24 h
(Fig. 7b).
Discussion
It has been widely shown that leptin is involved with dif-
ferent roles within the respiratory tract [2, 18], particularly
with proliferative and protective roles in bronchial
Fig. 5 rPar j 1, FF, and
cytokines affect leptin receptor
proteins in RPMI 2650 cells.
a Physical parameters and
overlay of fluorescence intensity
(FL1) related to the expression
of leptin receptor by flow-
cytometry analysis. b Data
(mean ± SD) from eight
independent experiments.
Significant difference * versus
medium; ** versus rPar J 1.
p \ 0.05, paired t test
Fig. 6 rPar j 1, FF, and cytokines affect leptin protein in RPMI 2650 cells. This panel shows data (mean ± SD) for leptin expression from eight
independent experiments. Significant difference * versus medium; ** versus rPar J 1. p \ 0.05, paired t test
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epithelial homeostasis [4, 6]. Allergen exposure is the first
cause of AR, and topic corticosteroids treatment is the only
efficient therapy to contrast its symptoms [9, 10]. Presently,
the literature lacks of in vitro evidences supporting the role
of leptin in nasal epithelial homeostasis both in the pre-
sence and in the absence of allergens. In the present study,
we demonstrate for the first time that FF contributes to
maintain, in vitro, the nasal epithelium homeostasis in
RPMI 2650 cells up-regulating leptin/leptin receptor
pathway and increasing cell proliferation. The FF effects
are dominant when compared to the allergen effects, since
they persist also when the cells are cultured with FF
combined with rPar j.
The following new findings are reported: First, leptin
and leptin receptor are expressed by RPMI 2650 cells
(Fig. 1) and, in ex vivo conditions, by nasal epithelial cells
(Fig. 2). Second, rPar j 1 and TGF-b1 are able to signifi-
cantly decrease cell proliferation (Fig. 3) other than to
significantly decrease the leptin receptor expression both as
mRNA (Fig. 4) and as protein expression (Fig. 5)
expression. rPar j 1 is also able to significantly decrease
leptin expression (Fig. 6). Third, FF significantly increases
RPMI 2650 cell proliferation and the leptin/leptin receptors
pathway expression, either in absence or in presence of
rPar j 1 (Figs. 3, 5, 6). Fourth, leptin itself is able to sig-
nificantly increase RPMI 2650 cell proliferation (Fig. 3)
and the leptin/leptin receptor pathway expression (Figs. 4,
5, 6), either in absence or in presence of FF. Pharmaco-
logical JAK2 inhibitor AG 490 completely abolishes lep-
tin’s activity on cell proliferation (Fig. 3). To our
knowledge, this is the first in vitro study that evaluates the
role of FF, alone or combined with rPar j 1 and with leptin,
on cell proliferation and on the leptin/leptin receptors
pathway expression.
The major allergen rParj 1 used in our experimental
in vitro design is a specific isoform of 102 aminoacids
(fully named Par j 1.0201). This isoform, despite has an
almost undetectable endogenous endotoxin content
(B0.003 ng LPS/lg of recombinant protein) [14] lacks, for
its nature, of the aminoacidic tail that binds LPS. On the
Fig. 7 rPar j 1, FF, and leptin affect STAT-3 nuclear translocation.
STAT-3 nuclear translocation was assessed by western blot analysis
on cytoplasmic and nuclear extracts, and the expression of STAT-3
was assessed using a monoclonal antibody anti-STAT-3. Membranes
were then stripped and incubated with goat polyclonal anti-b-actin
and with rabbit polyclonal anti-lamin B1. a The STAT-3 activation
was assessed in cells cultured with rPar j 1, FF, and leptin alone and in
combination after 24 h of incubation. Signals corresponding to
nuclear STAT-3 expression on the various western blots were
semiquantified by densitometric scanning, normalized, and expressed
after correction with the density of the bands obtained for beta-actin
and lamin B1. Data are expressed as arbitrary units ± SD.
* p \ 0.05. Representative western blot analyses from five indepen-
dent experiments were shown. b Time course (30 min, 1 h, 4 h, and
24 h) for leptin effects. Signals corresponding to nuclear STAT-3
expression on the various western blots were semiquantified by
densitometric scanning, normalized, and expressed after correction
with the density of the bands obtained for beta-actin and lamin B1.
Representative western blot analyses from three independent
experiments
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contrary, the longer isoform of the major allergen Parj 1
(fully named Par j 1.0101) is a specific isoform of 139
aminoacids containing also the LPS site binding [19]. It is
well known that the total pollen extract is a mix of all
allergens minor and major, but it is not standardized for
each of major allergen [15] that contains all isoforms,
included also the longer isoform of the major allergen Parj
1, and than it is able to activate several intracellular sig-
naling, including the leptin/leptin receptor pathway. These
evidences further support the hypothesis that a purified
major allergen, as Par j 1.0101 is able to induce, in an
in vitro model, a negative modulation of the protective
pathway of leptin and its receptor. Particularly, we
observed that the major allergen rParj 1 used in our
experimental in vitro design is able to significantly
decrease leptin protein as well as its receptor expression.
Here, recombinant human leptin is able to significantly
increase both itself and its receptor protein expression.
Interestingly, we found that the recombinant human fibr-
ogenic cytokine TGF-b1 modulates leptin/leptin receptor
pathway reducing only leptin receptor expression. The role
of TGF-b1 is relevant in a long-term experimental condi-
tion (clonogenic test), since it exerts an anti-proliferative
role, also by counteracting the exogenous recombinant
human leptin and the FF proliferative roles. The positive
regulation of cell proliferation is an event crucially
involved in the repair processes also in nasal epithelium. In
the nasal tract, upon injury, undifferentiated basal cells
migrate from adjacent epithelium, spread over the denuded
basement membrane, and proliferate in injured regions [7].
On the other hand, to better explain our results obtained by
stimulating RPMI 2650 cells with FF, alone or in combi-
nation with either major allergen rParj 1 and with leptin
itself, it has to be considered that intranasally administered
corticosteroids have a wide margin of safety and are the
mainstay of treatment for patients with moderate to severe
AR, non-allergic rhinitis, and nasal polyposis [20]. The
anti-inflammatory effects exerted by these drugs include
the decrease of eosinophil and basophil cell infiltrates, of
pro-inflammatory mediators, of vascular permeability, and
of mucus production [21]. Corticosteroids can also exert
immunomodulatory activities, since they can reduce the
number of Th2 lymphocytes [22]. The local anti-inflam-
matory effects of corticosteroids play a relevant role in
improving nasal epithelial histology. In this regard, it has
been previously demonstrated that fluticasone propionate
treatment for one year led to increased thickness of the
nasal epithelium [13] and also yearlong therapy with FF
increased the percentage of epithelium comprising intact
columnar and ciliated epithelial cells [21]. In our study,
only FF and leptin were able to modulate the expression of
leptin receptor at both mRNA and protein levels. rPRJ 1
was able to modulate leptin receptor expression but not
leptin receptor m-RNA. This discrepancy between leptin
receptor mRNA and protein expression could be due to
some post-transcriptional and/or post-translational pro-
cesses. With regard to leptin expression, all the other tested
stimuli were not able to modulate the m-RNA for leptin
suggesting that the increased leptin protein expression is
related to post-transcriptional regulatory events. Taken
together, these findings suggest a potential homeostatic role
of FF on the nasal epithelium, and the data from the present
study demonstrate that FF exerts this homeostatic role by
the activation of leptin/leptin receptor pathway in nasal
epithelial cells. Leptin, in fact, has been shown to be a
critical mediator of restitution following injury to the epi-
thelium. In this regard, our previous study performed
in vitro and ex vivo [6] concludes that firstly, in vitro the
human bronchial epithelial cells express leptin/leptin
receptors proteins, and fluticasone propionate increases
leptin receptors expression; secondly, ex vivo in endo-
bronchial biopsies from asthmatic patients of vary entities,
the leptin/leptin receptors pathway is inversely correlated
with features of remodeling as sub-epithelial thickness and
TGF-b1 expression, leading to the concept that the leptin/
leptin receptor pathway is involved in lung epithelial
homeostasis in asthma, and its expression decreases in
patients with uncontrolled and severe asthma. To reinforce
this message, also another our previous study [5] per-
formed ex vivo in endobronchial biopsies from COPD
patients reports that in epithelial cells, the expression of
leptin and its receptor is higher in healthy normal subjects
than in smokers or in mild-to-severe COPD patients.
Accordingly, in the present study, evaluating epithelial
cells in inferior turbinate of nasal biopsies from three
healthy not allergic control subjects and from three allergic
patients, we found that there is a negative trend of the
expression of leptin/leptin receptor pathway in the epithe-
lium from allergic patients supporting the hypothesis of
leptin as marker of epithelium homeostasis. On the other
hand, leptin deficiency could lead to altered immune
responses since this pathway affects both the innate and
acquired immune systems. In this regard, it has been
demonstrated that patients with reduced leptin levels have
reduced CD4 T-cell populations (thus a reduced CD4/CD8
ratio), hyporesponsive T-cells, severely reduced IFN-c
expression, and reduced levels of cytokines such as IL-10
and IL-4, while they have increased TGF-b levels. Upon
leptin replacement therapy, CD4 numbers, T-cell function,
and IFN-c expression were all recovered, and TGF-b levels
dropped to normal levels [23]. Based on all these evi-
dences, finally we performed further experiments, mainly
directed to deeper investigate the signaling transduction of
FF, leptin, and allergens in human nasal epithelial cells.
The long isoform of the leptin receptor contains intracel-
lular motifs required for the activation of multiple signaling
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including STAT-3. In this regard, it has been previously
demonstrated that leptin increases cell proliferation in
nucleus pulposus cells by up-regulating STAT-3 activation
[24]. We now demonstrate an activation of STAT-3 in
leptin stimulated nasal epithelial cells after 4 h but not after
24 h of incubation suggesting that, upon STAT-3 activa-
tion, a negative feedback loop may be activated in nasal
epithelial cells. Accordingly, leptin-induced signaling via
STAT-3 rapidly activates the negative feedback regulator
SOCS3, which inhibits leptin-induced signal transduction
[25]. After 24 h of incubation, rPar J 1 reduces while FF
increases STAT-3 activation and counteracts the effects of
rPar J 1 on STAT-3 activation. Leptin alone (at 4 and at
24 h) it was not able to revert the effect of rPar J 1 on
STAT-3 activation. These findings suggest that at longer
incubation time, FF might increase leptin/leptin receptor
pathway effects also preventing the downregulation of
STAT-3 activation due to allergen exposure.
Conclusions
In conclusion, the present study provides new evidences for
leptin activity in the nasal tract, strongly supporting the
concept that leptin could represent a key molecule for the
epithelial homeostasis also in the upper airways. Further-
more, FF in the presence of the allergens insults is able to
restore the leptin/leptin receptor pathway, supporting the
concept that leptin is involved in human nasal epithelial
homeostasis in AR.
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